- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07264504
Experimentation of Formaldehyde Purification by Plants in the Anatomy and Cytology Department (DETOXANAPATH)
December 2, 2025 updated by: Centre Hospitalier Universitaire, Amiens
Formaldehyde is notably used as a tissue fixator in pathological anatomy.
Despite its toxicity, it continues to be widely used because it is currently not substitutable.
Some plants have shown their ability to absorb formaldehyde.
The investigators would like to show if the installation of plants in the Anatomy and Cytology Department of the Amiens University Hospital reduces the exposure to formaldehyde of the staff of this department.
After carrying out atmospheric and biological measurements the investigators will install 15 plants in both rooms where the staff is most exposed to formaldehyde : the macroscopy room and the reception room.
The atmospheric and biological measurements will be redone after two months.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Denis CHATELAIN, Pr
- Phone Number: 33+32288281
- Email: chatelain.denis@chu-amiens.fr
Study Locations
-
-
-
Amiens, France, 80090
- Recruiting
- CHRU Amiens
-
Contact:
- Denis Chatelain, Pr
- Phone Number: 33+322088281
- Email: chatelain.denis@chu-amiens.fr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- To work in the Department of Pathological Anatomy and Cytology
- Adult (> 18 years old)
- Patient information and collection of non-opposition
Exclusion Criteria:
- Pregnant woman
- Patients under guardianship or safeguarding of justice
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: laboratory staff
Before / after installation of plants
|
Biological measurement of urinary formic acid
plant installation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Atmospheric formaldehyde concentration
Time Frame: 2 months
|
Variation of Atmospheric measurement of formaldehyde between before and after plant installation
|
2 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Variation of urinary formic acid concentration
Time Frame: 2 months
|
Variation of Biological measurement of urinary formic acid between before and after plant installation
|
2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 25, 2024
Primary Completion (Actual)
December 31, 2024
Study Completion (Estimated)
May 1, 2026
Study Registration Dates
First Submitted
May 6, 2025
First Submitted That Met QC Criteria
December 2, 2025
First Posted (Estimated)
December 4, 2025
Study Record Updates
Last Update Posted (Estimated)
December 4, 2025
Last Update Submitted That Met QC Criteria
December 2, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PI2023_843_0095
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Biological measurement of urinary formic acid
-
Fondation LenvalNot yet recruiting
-
Comenius UniversityTerminated
-
Herlev HospitalCompleted
-
Tanta UniversityCompletedDiagnosis of Acute Appendicitis in ChildrenEgypt
-
Herlev HospitalUnknown
-
Central Hospital, Nancy, FranceRecruiting
-
Assistance Publique - Hôpitaux de ParisUnknownSmoking | Carcinogenesis of the NicotineFrance
-
Centre Hospitalier Universitaire de NīmesActive, not recruiting
-
University Hospital, ToursRecruitingSickle Cell Disease | Acute Chest Syndrome | Sickle Cell Nephropathy | Vaso-Occlusive Crises | Glomerular HyperfiltrationFrance
-
University of LeipzigUnknownInflammation | Inflammatory Bowel Diseases | Tumor | Tissue PerfusionGermany